United Medical Systems expands mobile stereotactic biopsy operations with acquisition of Mobile Biopsy

NewsGuard 100/100 Score

United Medical Systems, Inc. announces the acquisition of Mobile Biopsy, Inc., a Statesville, North Carolina based company, for an undisclosed cash amount. The acquisition of Mobile Biopsy will expand UMS' mobile stereotactic biopsy operations throughout the southeastern section of the country. Mobile Biopsy operates seven mobile stereotactic biopsy units serving approximately 50 customers throughout Alabama, Florida, Georgia, New Jersey, North Carolina, Pennsylvania, South Carolina, Tennessee, and Virginia.

United Medical Systems is an international leader in shared medical services providing mobile services to over 625 hospitals and medical centers in 32 states, Canada and South America. Over the past 12 years, UMS has performed over 125,000 breast biopsies. Other mobile services include extracorporeal shockwave lithotripsy and laser treatment of BPH.

Medical facilities taking advantage of UMS' mobile services have seen significant cost reductions by eliminating expensive equipment purchases and unnecessary maintenance programs, among other things. UMS continuously upgrades and provides the latest state-of-the-art equipment.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Novel blood test shows promise in detecting early-stage cancers with high accuracy